GordonMD Invests In $150M Private Placement For Taysha Gene Therapies
Portfolio Pulse from Happy Mohamed
GordonMD® Global Investments LP has participated in a $150 million private placement financing for Taysha Gene Therapies, Inc. (NASDAQ:TSHA). The funds will be used to fund clinical development of TSHA-102 in Rett syndrome and support program activities for TSHA-120 in giant axonal neuropathy (GAN).
August 21, 2023 | 3:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Taysha Gene Therapies received a $150 million investment from GordonMD for clinical development of its gene therapies TSHA-102 and TSHA-120.
The investment will fund the clinical development of Taysha's gene therapies, which could potentially lead to FDA approval and commercialization. This could increase the company's revenues and profitability, positively impacting its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100